Clearmind Medicine (CMND) Operating Income (2022 - 2023)
Clearmind Medicine's (CMND) quarterly Operating Income came in at -$1.2 million in Q2 2023, up 33.22% quarter-over-quarter from -$1.8 million in Q1 2023.
Powered by 
Analysis
Clearmind Medicine (CMND) Operating Income (2022 - 2023) Analysis & Trends
Clearmind Medicine (CMND) has reported Operating Income for 2 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Clearmind Medicine | 14,742.44 | -13.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2023 | -1.22 Mn |
| Jan 31, 2023 | -1.83 Mn |
| Jan 31, 2022 | -1.65 Mn |